News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xoft Inc.: 12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting


4/28/2010 10:27:19 AM

LAS VEGAS, April 28 /PRNewswire/ -- Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBx™, System to deliver intraoperative radiation therapy (IORT) is growing as clinical experience demonstrates the isotope-free cancer treatment platform is a patient and physician friendly alternative. Xoft will showcase a variety of IORT oncology applications at the 11th Annual Meeting of the American Society of Breast Surgeons here, April 28-May 2, 2010.

Read at PR Newswire


comments powered by Disqus
Xoft Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES